Literature DB >> 15863892

Inhibitory effects of cancer cell proliferation by novel histone deacetylase inhibitors involve p21/WAF1 induction and G2/M arrest.

Taishi Maeda1, Yasuo Nagaoka, Yuki Kawai, Nobumasa Takagaki, Chikako Yasuda, Shingo Yogosawa, Yoshihiro Sowa, Toshiyuki Sakai, Shinichi Uesato.   

Abstract

Two compounds were synthesized which have a structural component other than those of our new series histone deacetylase (HDAC) inhibitors to determine the structure-activity relationship. It was also examined whether the inhibitory effects on cancer cell proliferation by HDAC inhibitors involve p21/WAF1 induction and G(1) or G(2)/M arrest in p53-mutated MG63 human osteosarcoma cells as do other HDAC inhibitors. It was demonstrated that inhibitors with the 2-naphthylcarbonyl group and hydroxamic acid at both termimal sides as well as the phenylene component at the center of molecule markedly induce the p21/WAF1 protein by stimulating p21/WAF1 gene promoter activity. Furthermore, cell cycle analysis revealed that these compounds arrest MG63 cells in the G(2)/M phase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15863892     DOI: 10.1248/bpb.28.849

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells.

Authors:  Eun-Taex Oh; Moon-Taek Park; Bo-Hwa Choi; Seonggu Ro; Eun-Kyung Choi; Seong-Yun Jeong; Heon Joo Park
Journal:  Invest New Drugs       Date:  2010-10-27       Impact factor: 3.850

2.  Role of epigenetic modulation for the treatment of sarcoma.

Authors:  Gregory M Cote; Edwin Choy
Journal:  Curr Treat Options Oncol       Date:  2013-09

3.  Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenografts.

Authors:  Yuen-Li Chung; Helen Troy; Rebecca Kristeleit; Wynne Aherne; L Elizabeth Jackson; Peter Atadja; John R Griffiths; Ian R Judson; Paul Workman; Martin O Leach; Mounia Beloueche-Babari
Journal:  Neoplasia       Date:  2008-04       Impact factor: 5.715

4.  By recruiting HDAC1, MORC2 suppresses p21 Waf1/Cip1 in gastric cancer.

Authors:  Qing Zhang; Yanyan Song; Wei Chen; Xiaohui Wang; Zhifeng Miao; Liu Cao; Feng Li; Guiling Wang
Journal:  Oncotarget       Date:  2015-06-30

Review 5.  Anticancer Activity, Mechanism, and Delivery of Allyl Isothiocyanate.

Authors:  Ammar Tarar; Sarah Peng; Soha Cheema; Ching-An Peng
Journal:  Bioengineering (Basel)       Date:  2022-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.